Answers are grounded in this paper and cite their sources.
Quality improvement project reveals anaesthetic assessment may delay cancer surgery in high-risk patients, suggesting pathway adjustments are needed.
Aims This quality improvement project aimed to evaluate whether anaesthetic assessment (AA) for patients at high risk of general anaesthesia (GA) results in a delay to 62-day cancer pathway. Methods Patient records were reviewed retrospectively from June to October 2024 to identify patients who required anaesthetic assessment after review in nurse led pre-operative assessment. Information was also collected on other demographic features including ASA grade and NABCOP (National Audit of Breast Cancer in Older Patients) assessment (for patients over 70). Results 73.2% patients met the 62-day target during the period stated. 26 patients required AA prior to breast surgery (mean- age :74 years; BMI :30kg/m2. The mode ASA score was III (n=17) and mode Rockwood frailty score was 6 (n=6). The mean time between listing for surgery and appointment for AA was 18.4 days (range 5-38). The mean time from AA and surgery was 20.8 days (range1-83). The patient who waited 83 days was commenced on Letrozole, was eventually optimised for surgery. Understandably, 30.7% (n=8) patients who had an AA in this time had breached the 62-day cancer pathway target. Conclusions In conclusion, AA prior to breast cancer surgery is a priority for timely delivery of treatment. Therefore, with collaboration with anaesthetists, pre-operative team we have designed an acute referral pathway and have increased AA clinic capacity. We aim to reduce waiting time to surgery for cancer patients, our initial analysis of this pathway is already reflecting an improvement in cancer care.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: